$559.50 $559.50 Unit price per Westend Medical 0.9% Sodium Chloride Injection, USP (20 mL bottle) $12.80 $12.80 Unit price per EXP: 31 MAR 2027 Brand: Hospira LifeShield Flip-top Plastic Saline Vial for Injection, Preservative-Free This sterile 0.9% saline solution is designed solely for parenteral use only after the addition of drugs that require dilution or must be dissolved in an aqueous vehicle prior to
If you are experiencing a vitamin B12 deficiency, you may notice increased energy and reduced fatigue within just a few days after your injection at Noor Medical Spa
No more waiting rooms or missing work
1% AHK-Cu (Copper Tripeptide-3)
BOTTOM LINE: Those at greatest risk of vitamin B12 deficiency are vegans and vegetarians, who get little to no B12 from the diet

Peripheral receptor activity may contribute to effects such as temporary blood pressure changes or skin pigmentation Potential Benefits & Considerations Research and clinical observations suggest: May support improvements in sexual desire and arousal Has shown positive outcomes in clinical populations with reduced desire Early findings indicate potential benefits across both men and women Considerations: Most commonly reported effects include nausea, flushing, and headache Temporary increases in blood pressure may occur Not suitable for individuals with uncontrolled cardiovascular conditions Repeated use may lead to mild, reversible skin darkening Lifestyle Factors Supporting habits can improve overall outcomes: Maintain a balanced diet and regular exercise routine Prioritize sleep quality , as it directly impacts hormonal balance Manage stress through relaxation techniques or mindfulness practices Limit alcohol intake, which may reduce overall effectiveness Injection Technique Clean the vial and injection site with alcohol and allow to dry Pinch a small fold of skin and insert the needle at a 4590 angle Inject slowly and steadily (do not aspirate) Rotate injection sites regularly (abdomen, thighs) Dispose of syringes safely after each use Intranasal (IN) Research Summary Bremelanotide was originally developed and studied for intranasal (IN) delivery before the subcutaneous (SC) formulation was selected for FDA approval
